Business Description
Ironwood Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US46333X1081
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.17 | |||||
Equity-to-Asset | -0.81 | |||||
Debt-to-Equity | -1.99 | |||||
Debt-to-EBITDA | 5.27 | |||||
Interest Coverage | 3.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.06 | |||||
Beneish M-Score | -4.51 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year FCF Growth Rate | 4.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.74 | |||||
9-Day RSI | 49.49 | |||||
14-Day RSI | 45.95 | |||||
6-1 Month Momentum % | -47.4 | |||||
12-1 Month Momentum % | -57.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.92 | |||||
Quick Ratio | 3.92 | |||||
Cash Ratio | 2.32 | |||||
Days Sales Outstanding | 91.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -27.28 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 31.56 | |||||
Net Margin % | 2.3 | |||||
FCF Margin % | 36.5 | |||||
ROE % | Neg. Equity | |||||
ROA % | 1.89 | |||||
ROIC % | 2.36 | |||||
ROC (Joel Greenblatt) % | 181.12 | |||||
ROCE % | 46.94 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 103.75 | |||||
Forward PE Ratio | 9.11 | |||||
PE Ratio without NRI | 37.73 | |||||
Price-to-Owner-Earnings | 6.16 | |||||
PS Ratio | 1.71 | |||||
Price-to-Free-Cash-Flow | 4.63 | |||||
Price-to-Operating-Cash-Flow | 4.62 | |||||
EV-to-EBIT | 10.11 | |||||
EV-to-EBITDA | 9.93 | |||||
EV-to-Revenue | 3.02 | |||||
EV-to-FCF | 8.18 | |||||
Price-to-Projected-FCF | 0.67 | |||||
Price-to-Median-PS-Value | 0.35 | |||||
Earnings Yield (Greenblatt) % | 9.9 | |||||
FCF Yield % | 21.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ironwood Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 370.95 | ||
EPS (TTM) (€) | 0.038 | ||
Beta | 0.22 | ||
Volatility % | 60.36 | ||
14-Day RSI | 45.95 | ||
14-Day ATR (€) | 0.14327 | ||
20-Day SMA (€) | 3.821 | ||
12-1 Month Momentum % | -57.57 | ||
52-Week Range (€) | 3.52 - 14.5 | ||
Shares Outstanding (Mil) | 159.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ironwood Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ironwood Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ironwood Pharmaceuticals Inc Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc(FRA:I76)'s stock price today?
When is next earnings date of Ironwood Pharmaceuticals Inc(FRA:I76)?
Does Ironwood Pharmaceuticals Inc(FRA:I76) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |